Creative Medical Technology Holdings Inc. is a commercial stage biotechnology company focused on a regenerative approach to Immunotherapy, Urology, Neurology and Orthopedics. Creative Medical Technology Holdings Inc. is based in PHOENIX.
Info & Links
CEO
Timothy Warbington
Headquarters
211 E. OSBORN ROAD PHOENIX, AZ 85012, UNITED STATES
Creative Medical Technology Holdings Inc Statistics
Valuation Measures
Market Capitalization2
4.01M
Enterprise Value
-2.25M
Enterprise Value/EBITDA(ttm)
0.41
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
--
Price to Book(mrq)
0.58
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
30.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
-18856.02%
Return on Equity(ttm)
-63.05%
Return on Invested Capital(ttm)
-63.84%
Return on Assets(ttm)
-60.42%
Income Statement
Revenue(ttm)
11.00K
Revenue Per Share(ttm)
0.01
Gross Profit(ttm)
6.60K
EBITDA(ttm)3
-5.52M
Net Income Available to Common(ttm)
-5.32M
Diluted EPS(ttm)
-3.80
Share Statistics
Beta (5Y Monthly)
1.76
52-Week Change
-49.56%
S&P 500 52-Week Change
26.89%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
1.75M
Dividend Yield
0.00%
Float4
1.70M
% Held by Insiders
2.80%
% Held by Institutions
1.42%
Balance Sheet
Total Cash(mrq)
6.26M
Total Cash Per Share(mrq)
3.58
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
19.13%
Quick Ratio(mrq)
19.12%
Book Value Per Share(mrq)
4.93
Cash Flow
Operating Cash Flow Per Share(ytd)
-2.41
Free Cash Flow(ytd)
-3.35M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.